GRAND PHARMA(00512),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

00512 GRAND PHARMA

Trading 06-03 15:28:39

5.160

-0.120

-2.27%

High5.300	Low5.130	Vol3.72M
Open5.300	D1 Closing5.280	Amplitude3.22%
Mkt Cap18.32B	Tradable Cap18.32B	Total Shares3.55B
T/O19.23M	T/O Rate0.10%	Tradable Shares3.55B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"00512","market":"HK","secType":"STK","nameCN":"GRAND PHARMA","latestPrice":5.16,"timestamp":1780471718772,"preClose":5.28,"halted":0,"volume":3717999,"delay":0,"changeRate":-0.022727272727272745,"floatShares":3549571148,"shares":3550000000,"eps":0.3544,"marketStatus":"Trading","change":-0.12,"latestTime":"06-03 15:28:39","open":5.3,"high":5.3,"low":5.13,"amount":19229169,"amplitude":0.032197,"askPrice":5.16,"askSize":55000,"bidPrice":5.14,"bidSize":39500,"shortable":3,"etf":0,"ttmEps":0.3544,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1780474200000},"marketStatusCode":2,"adr":0,"listingDate":819302400000,"exchange":"SEHK","adjPreClose":5.28,"dividendRate":0.050388,"openAndCloseTimeList":[[1780450200000,1780459200000],[1780462800000,1780473600000]],"volumeRatio":0.47135,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00512","defaultTab":"news","newsList":[{"id":"1192987510","title":"GRAND PHARMA's Nuclear Medicine Partner Telix Achieves Key Milestone in Overseas Phase I Study for Novel Product TLX101 in Newly Diagnosed Glioblastoma","url":"https://stock-news.laohu8.com/highlight/detail?id=1192987510","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192987510?lang=en_us&edition=fundamental","pubTime":"2026-05-21 13:11","pubTimestamp":1779340289,"startTime":"0","endTime":"0","summary":"Recent updates indicate that GRAND PHARMA (00512), an innovative international pharmaceutical company listed in Hong Kong, has made further progress in nuclear medicine research and development. The...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","00512"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193240675","title":"Grand Pharma’s April 2026 HKEX Filing Shows No Change to 3.55 Billion Issued Shares, Public Float Remains Compliant","url":"https://stock-news.laohu8.com/highlight/detail?id=1193240675","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193240675?lang=en_us&edition=fundamental","pubTime":"2026-05-04 17:10","pubTimestamp":1777885827,"startTime":"0","endTime":"0","summary":"Grand Pharmaceutical Group Limited (Grand Pharma) filed its Monthly Return for Equity Issuer to Hong Kong Exchanges and Clearing Limited covering the period ended 30 April 2026. The document confirms...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00512"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183921331","title":"国控医药2025年营收稳步增长，核医学与重症治疗创新布局多项成果","url":"https://stock-news.laohu8.com/highlight/detail?id=1183921331","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183921331?lang=en_us&edition=fundamental","pubTime":"2026-04-29 20:28","pubTimestamp":1777465715,"startTime":"0","endTime":"0","summary":"2025年，医药制造业面临增速下滑和PPI走低等行业压力，但本地创新药研发持续加快，医药行业正从传统仿制药向高附加值疗法加速转型。国控医药（GRAND...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"国控医药2025年营收稳步增长，核医学与重症治疗创新布局多项成果","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00512"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129138230","title":"Grand Pharma: 2025 Revenue Rises to HK$12.28 Billion, R&D Spend Hits HK$1.46 Billion and Dividend Totals HK$600 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1129138230","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129138230?lang=en_us&edition=fundamental","pubTime":"2026-04-29 20:26","pubTimestamp":1777465596,"startTime":"0","endTime":"0","summary":"Grand Pharmaceutical Group Limited (Grand Pharma) released its 2025 Environmental, Social and Governance Report, outlining solid operating growth, expanded R&D investment and upgraded sustainability...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00512"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173381469","title":"Grand Pharma Plans Bye-Law Overhaul to Meet HKEX Paperless, Treasury Share Requirements","url":"https://stock-news.laohu8.com/highlight/detail?id=1173381469","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173381469?lang=en_us&edition=fundamental","pubTime":"2026-04-29 20:25","pubTimestamp":1777465509,"startTime":"0","endTime":"0","summary":"Grand Pharmaceutical Group Limited (Grand Pharma) has announced a proposal to replace its existing bye-laws with a new set designed to align with forthcoming Hong Kong Stock Exchange (HKEX)...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00512"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162112852","title":"Grand Pharma Sets 5 June 2026 AGM; Proposes HK$0.169 Final Dividend and New Share Mandates","url":"https://stock-news.laohu8.com/highlight/detail?id=1162112852","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162112852?lang=en_us&edition=fundamental","pubTime":"2026-04-29 20:24","pubTimestamp":1777465467,"startTime":"0","endTime":"0","summary":"Grand Pharmaceutical Group Limited (Grand Pharma) has called its Annual General Meeting (AGM) for 11:00 a.m. on 5 June 2026 at Unit 3302, The Center, 99 Queen’s Road Central, Hong Kong. The board...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00512"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127723479","title":"Grand Pharmaceutical Group Releases 2025 Annual Report and Shifts to Full Electronic Dissemination","url":"https://stock-news.laohu8.com/highlight/detail?id=1127723479","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127723479?lang=en_us&edition=fundamental","pubTime":"2026-04-29 20:24","pubTimestamp":1777465460,"startTime":"0","endTime":"0","summary":"Grand Pharmaceutical Group Limited announced on 30 April 2026 that its latest Annual Report and accompanying Circular are now available in both English and Chinese on the company website...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00512"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117128885","title":"Grand Pharma Tables 20% Issuance Mandate, HK$0.169 Dividend Ahead of 5 June AGM","url":"https://stock-news.laohu8.com/highlight/detail?id=1117128885","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117128885?lang=en_us&edition=fundamental","pubTime":"2026-04-29 20:24","pubTimestamp":1777465452,"startTime":"0","endTime":"0","summary":"Grand Pharmaceutical Group Limited will hold its 2026 annual general meeting (AGM) on 5 June in Hong Kong, seeking shareholder approval for a series of capital-management mandates, director...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00512"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186792552","title":"Grand Pharma Sets 5 June 2026 AGM; Proposes HK$0.169 Final Dividend, Director Re-elections and Bye-law Update","url":"https://stock-news.laohu8.com/highlight/detail?id=1186792552","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186792552?lang=en_us&edition=fundamental","pubTime":"2026-04-29 20:23","pubTimestamp":1777465418,"startTime":"0","endTime":"0","summary":"Grand Pharmaceutical Group Limited (Grand Pharma) has issued the proxy form for its annual general meeting scheduled for 11:00 a.m. on 5 June 2026 at Unit 3302, The Center, 99 Queen’s Road Central,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00512"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631191385","title":"Grand Pharmaceutical proposes adopting new bye-laws to align with paperless listing regime","url":"https://stock-news.laohu8.com/highlight/detail?id=2631191385","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631191385?lang=en_us&edition=fundamental","pubTime":"2026-04-29 20:15","pubTimestamp":1777464954,"startTime":"0","endTime":"0","summary":"Grand Pharmaceutical Group plans to replace existing bye-laws with a new set, subject to shareholder approval by special resolution.Changes aim to align governance with expanded paperless listing rules, electronic corporate communications, treasury shares regime.Amendments also target implementation of an uncertificated securities market.Vote will be put to shareholders at annual general meeting scheduled for June 5, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grand Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 29, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL4RRwKk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00512","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631196725","title":"Grand Pharma releases 2025 ESG report","url":"https://stock-news.laohu8.com/highlight/detail?id=2631196725","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631196725?lang=en_us&edition=fundamental","pubTime":"2026-04-29 20:13","pubTimestamp":1777464787,"startTime":"0","endTime":"0","summary":"Grand Pharma issued its third ESG report, covering environmental, social, governance performance for fiscal 2025.Operating revenue reached about HK$ 12.28 billion, up 5.5% year on year.R&D investment totaled HK$ 1.46 billion, supporting 131 projects.Environmental engineering protection spending was RMB 11.57 million, supported by 6,415 MWh of green electricity transactions and consumption.Public welfare investment was about RMB 63.3 million, up 195% year on year.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grand Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 29, 2026, and is solely responsible for t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL825sHy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","00512"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631519540","title":"Grand Pharmaceutical publishes 2025 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2631519540","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631519540?lang=en_us&edition=fundamental","pubTime":"2026-04-29 20:12","pubTimestamp":1777464755,"startTime":"0","endTime":"0","summary":"Grand Pharma published its 2025 annual report, highlighting strategic shift toward innovation-led growth and global expansion.Nuclear medicine oncology diagnostics and therapeutics remained key growth driver, supported by continued ramp-up of YiGanTai Yttrium-90 microsphere franchise.YiGanTai secured an additional FDA indication in 2025, positioning it as an FDA-cleared SIRT option for unresectable HCC plus colorectal cancer liver metastases.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grand Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 29, 2026, and is solely responsible for the information contai","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDLbkvcxp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00512","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631195895","title":"Grand Pharmaceutical Group announces annual general meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2631195895","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631195895?lang=en_us&edition=fundamental","pubTime":"2026-04-29 20:09","pubTimestamp":1777464569,"startTime":"0","endTime":"0","summary":"Grand Pharmaceutical Group will hold annual general meeting in Hong Kong on June 5, 2026.Shareholders will vote on adoption of audited financial statements for year ended Dec. 31, 2025.Final dividend of HK$ 0.169 per share is proposed.Meeting will consider re-election of directors, including Zhou Chao, Hu Yebi, Pei Geng.Other items include auditor reappointment, share issuance mandate, share repurchase mandate, amendments to bye-laws.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grand Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 29, 2026, and is solely responsible for the information contained ther","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL9pPj73:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00512","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124349459","title":"Grand Pharmaceutical Announces Transition to Electronic Dissemination of Corporate Communications","url":"https://stock-news.laohu8.com/highlight/detail?id=1124349459","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124349459?lang=en_us&edition=fundamental","pubTime":"2026-04-29 20:04","pubTimestamp":1777464243,"startTime":"0","endTime":"0","summary":"Grand Pharmaceutical Group Limited informed registered shareholders of the release of its latest Annual Report, Circular and Proxy Form, now accessible in both English and Chinese on the company’s...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00512"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108243664","title":"Chairman Tang Weikun Acquires 50,000 Shares of Grand Pharma at HK$6.47 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=1108243664","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108243664?lang=en_us&edition=fundamental","pubTime":"2026-04-22 20:11","pubTimestamp":1776859912,"startTime":"0","endTime":"0","summary":"According to the latest data from the Hong Kong Stock Exchange, on April 22, Chairman Tang Weikun purchased 50,000 shares of Grand Pharma at a price of HK$6.472 per share, totaling HK$323,600....","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","EWH","00512"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629061514","title":"Assessing Grand Pharmaceutical Group (SEHK:512) Valuation After Positive DOORwaY90 Liver Cancer Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2629061514","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629061514?lang=en_us&edition=fundamental","pubTime":"2026-04-22 05:17","pubTimestamp":1776806272,"startTime":"0","endTime":"0","summary":"Grand Pharmaceutical Group (SEHK:512) just reported that its DOORwaY90 trial for SIR-Spheres Y-90 in unresectable hepatocellular carcinoma met its clinical endpoint, a key data point for investors watching its radiopharmaceutical pipeline.\nSee our latest analysis for Grand Pharmaceutical Group.\nThe DOORwaY90 success comes at a time when Grand Pharmaceutical Group’s short-term share price performance has been weak, with a 30-day share price return showing a decline of 5.35% and a 90-day share...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-512/grand-pharmaceutical-group-shares/news/assessing-grand-pharmaceutical-group-sehk512-valuation-after-2","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-512/grand-pharmaceutical-group-shares/news/assessing-grand-pharmaceutical-group-sehk512-valuation-after-2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DCF","BK1191","00512"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158284950","title":"Grand Pharma Shares Surge Over 4% as Breakthrough Nuclear Medicine SIR-Spheres® Yttrium-90 Microspheres Hit New Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=1158284950","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158284950?lang=en_us&edition=fundamental","pubTime":"2026-04-14 10:30","pubTimestamp":1776133848,"startTime":"0","endTime":"0","summary":"Grand Pharma (00512) saw its shares rise more than 4% during trading. At the time of writing, the stock was up 2.87%, trading at HK$6.80 with a turnover of HK$9.3711 million. On April 13, Grand...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","00512","SIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193260133","title":"GRAND PHARMA's Yttrium-90 Microsphere Injection Achieves Endpoints in US Liver Cancer Trial, Accelerating Global Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=1193260133","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193260133?lang=en_us&edition=fundamental","pubTime":"2026-04-13 21:23","pubTimestamp":1776086602,"startTime":"0","endTime":"0","summary":"A milestone has been reached for GRAND PHARMA's key nuclear medicine product, SIR-Spheres® Yttrium-90 (Y90) Microsphere Injection (YIGANTAI®). On April 13, the company announced that its US clinical...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00512","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627455171","title":"BRIEF-Grand Pharmaceutical Says SIR-Spheres Y-90 Microsphere Injection US HCC Study Reaches Clinical Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2627455171","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627455171?lang=en_us&edition=fundamental","pubTime":"2026-04-13 21:18","pubTimestamp":1776086321,"startTime":"0","endTime":"0","summary":"BRIEF-Grand Pharmaceutical Says SIR-Spheres Y-90 Microsphere Injection US HCC Study Reaches Clinical EndpointApril 13  - Grand Pharmaceutical Group Ltd 0512.HK:SIR-SPHERES Y-90 MICROSPHERE INJECTION US HCC STUDY REACHES CLINICAL ENDPOINTFurther company coverage: 0512.HK ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nFWN40W0VE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00512","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627559354","title":"Grand Pharma says US DOORwaY90 trial of SIR-Spheres Y-90 in HCC hits endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2627559354","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627559354?lang=en_us&edition=fundamental","pubTime":"2026-04-13 21:11","pubTimestamp":1776085914,"startTime":"0","endTime":"0","summary":"Grand Pharmaceutical reported its US DOORwaY90 study of SIR-Spheres Y-90 resin microsphere injection in unresectable liver cancer reached its clinical endpoint.Study outcomes showed strong tumor response with durable benefit while preserving liver function, supporting Y-90 radioembolization as a definitive treatment option for unresectable disease.FDA had already cleared SIR-Spheres for unresectable hepatocellular carcinoma based on interim DOORwaY90 data, making it first selective internal radiotherapy product with dual US indications in liver cancer and colorectal cancer liver metastases.Grand Pharma flagged nuclear medicine segment revenue of about HK$950 million in 2025, up 61%, with SIR-Spheres cited as key growth driver.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nNDL7V1X8T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00512","BK1191"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.chinagrandpharm.com","stockEarnings":[{"period":"1week","weight":-0.033},{"period":"1month","weight":-0.1511},{"period":"3month","weight":-0.2521},{"period":"6month","weight":-0.3569},{"period":"1year","weight":-0.3952},{"period":"ytd","weight":-0.3274}],"compareEarnings":[{"period":"1week","weight":0.0171},{"period":"1month","weight":0.0102},{"period":"3month","weight":0.0312},{"period":"6month","weight":0.0039},{"period":"1year","weight":0.1244},{"period":"ytd","weight":0.0159}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Grand Pharmaceutical Group Ltd is an investment holding company mainly engaged in the pharmaceutical business. The Company is mainly engaged in the manufacture and sale of pharmaceutical preparations and medical devices. The Company is also engaged in the manufacture and sale of biotechnology products, health products, specialised pharmaceutical raw materials and other products. The Company's main products include nuclear medicine anti-tumor diagnosis and treatment and cardiovascular and cerebrovascular interventional diagnosis and treatment technology products.","yearOnYearQuotes":[{"month":1,"riseRate":0.451613,"avgChangeRate":0.084101},{"month":2,"riseRate":0.709677,"avgChangeRate":0.105021},{"month":3,"riseRate":0.387097,"avgChangeRate":0.015578},{"month":4,"riseRate":0.612903,"avgChangeRate":0.014044},{"month":5,"riseRate":0.451613,"avgChangeRate":0.07653},{"month":6,"riseRate":0.387097,"avgChangeRate":-0.046458},{"month":7,"riseRate":0.366667,"avgChangeRate":-0.015905},{"month":8,"riseRate":0.4,"avgChangeRate":0.007133},{"month":9,"riseRate":0.466667,"avgChangeRate":-0.039275},{"month":10,"riseRate":0.5,"avgChangeRate":-0.014834},{"month":11,"riseRate":0.5,"avgChangeRate":0.085694},{"month":12,"riseRate":0.5,"avgChangeRate":-0.007596}],"exchange":"SEHK","name":"GRAND PHARMA","nameEN":"GRAND PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GRAND PHARMA(00512),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest GRAND PHARMA(00512) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"GRAND PHARMA,00512,GRAND PHARMA股票,GRAND PHARMA股票老虎,GRAND PHARMA股票老虎国际,GRAND PHARMA行情,GRAND PHARMA股票行情,GRAND PHARMA股价,GRAND PHARMA股市,GRAND PHARMA股票价格,GRAND PHARMA股票交易,GRAND PHARMA股票购买,GRAND PHARMA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GRAND PHARMA(00512),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest GRAND PHARMA(00512) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}